Genmab A (GMAB) Current Taxes (2018 - 2025)

Genmab A (GMAB) has reported Current Taxes for 8 consecutive years, with $43.0 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Current Taxes fell 72.97% year-over-year to $43.0 million; the trailing twelve-month figure through Dec 2025 stood at $43.0 million (down 72.97% YoY), and the FY2025 full-year result was $43.0 million, down 82.01% from the prior year.
• Current Taxes grew to $43.0 million in Q4 2025 per GMAB's latest filing, from -$217.0 million in the prior quarter.
• Across five years, Current Taxes topped out at $159.1 million in Q4 2024 and bottomed at -$725.0 million in Q3 2021.
• Historically, Current Taxes has averaged -$66.8 million across 5 years, with a median of -$17.2 million in 2023.
• The widest YoY moves for Current Taxes: up 3036.27% in 2024, down 653.29% in 2024.
• Over 5 years, Current Taxes stood at $87.0 million in 2021, then slumped by 260.13% to -$139.3 million in 2022, then surged by 103.64% to $5.1 million in 2023, then soared by 3036.27% to $159.1 million in 2024, then sank by 72.97% to $43.0 million in 2025.
• According to Business Quant data, Current Taxes over the past three periods registered $43.0 million, -$217.0 million, and $40.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.